Mary T Szela Prometheus Biosciences, Inc. (RXDX) insider trading activity

RXDX Quotes by TradingView

Mary T Szela is Director of Prometheus Biosciences, Inc.. Currently has a direct ownership of 0 shares of RXDX, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 2,071 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mary T Szela Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Sale (or disposition) back to the issuer
-
2,071 Reduced 100.0%
0 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
2,071 Added 50.0%
2,071 Common Stock

Also insider at

CHRS
Coherus BioSciences, Inc. Healthcare
Director
KURA
Kura Oncology, Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
MTACW
MedTech Acquisition Corp
CEO AND PRESIDENT
MTS

Mary T Szela

Director
San Diego, CA

Track Institutional and Insider Activities on RXDX

Follow Prometheus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXDX shares.

Notify only if

Insider Trading

Get notified when an Prometheus Biosciences, Inc. insider buys or sells RXDX shares.

Notify only if

News

Receive news related to Prometheus Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXDX